Canaccord Genuity Starts Dimension Therapeutics (DMTX) at Buy
Tweet
Share
E-mailGet Alerts DMTX Hot Sheet
Price: $5.95 --0%
Rating Summary:
2 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 7 | New: 64
Rating Summary:
2 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 7 | New: 64
Join SI Premium – FREE
Canaccord Genuity initiated coverage on Dimension Therapeutics (NASDAQ: DMTX) with a Buy rating and a price target of $20.00.
For an analyst ratings summary and ratings history on Dimension Therapeutics click here. For more ratings news on Dimension Therapeutics click here.
Shares of Dimension Therapeutics closed at $13.88 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Silver Storm closes $21M private placement with second tranche
- Morgan Stanley Resumes Vertex (VRTX) at Overweight
- Maxim Group Starts BioVersys AG (BIOV:SW) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
Canaccord GenuitySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
